TARSONSBSETarsons Products LtdMinimalNeutral
Announced Tue, 19 May · 19:00 IST

Annual Secretarial Compliance Report for the financial year ended March 31, 2026

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.6%1-day move
₹212.00
prior close
₹211.38
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.1-0.2-0.2-0.6+2.8+0.7+4.2+1.4-1.9-5.1+27.1+33.1
Up moveDown movePending
AI summary

Tarsons Products Limited has filed its Annual Secretarial Compliance Report for FY 2025-26 with BSE and NSE, as required under SEBI regulations. The report was issued by Practicing Company Secretary Manisha Saraf & Associates. The secretarial audit covered compliance with key SEBI regulations including LODR, Substantial Acquisition of Shares and Takeovers, Insider Trading, and Depositories regulations. All 13 compliance checkpoints verified by the PCS returned a "Yes" status with no observations or violations reported. The company has one wholly-owned subsidiary (Tarsons Life Science Pte. Ltd.) and two step-down subsidiaries, with Nerbe Plus GMBH & Co. KG identified as a material subsidiary. No actions were taken by SEBI or stock exchanges against the company during the review period.

Likely market impact

This is a positive compliance report indicating the company maintained good governance and regulatory adherence throughout FY 2025-26. Shareholders can view this as confirmation that the company follows proper board processes and disclosure requirements.